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Abstract
Objective: The angiotensin II (AngII)-infused apolipoprotein E-deficient (ApoE2/2) mouse model is widely used to study
atherosclerosis and abdominal aortic aneurysm. An increase in blood pressure has been reported in this model however the
underlying mechanism has not been fully explored. In this study, we investigated whether vasomotor dysfunction develops
in AngII-infused ApoE2/2 mice and the underlying mechanism involved.
Methods: ApoE2/2 mice were infused with vehicle (distilled water) or AngII subcutaneously for 14 days. Blood pressure and
heart rate were measured using the non-invasive tail cuff method. Aortic vascular reactivity and expression of key proteins
(endothelial nitric oxide synthase (eNOS), phospho-eNOS and caveolin-1) were assessed using tension myography and
Western blotting respectively. Plasma nitric oxide (NO) level was estimated using a colorimetric assay.
Results: AngII infusion caused a time-dependent increase in blood pressure (P,0.001). Aortas from AngII-infused mice were
significantly less responsive to acetylcholine-induced endothelium-dependent relaxation when compared to aortas from
mice infused with vehicle control (P,0.05). Contractile responses to phenylephrine (P,0.01) and potassium chloride
(P,0.001) were significantly enhanced in aortas from AngII-infused mice. eNOS phosphorylation was significantly decreased
in the aorta of AngII-infused mice (P,0.05). Aortic caveolin-1 protein expression was significantly increased in AngII-infused
mice (P,0.05). Plasma nitrate/nitrite level was significantly reduced in AngII-infused mice (P,0.05). Pharmacological
disruption of caveolae using methyl-b-cyclodextrin (MbCD) in isolated aortas from AngII-infused mice caused a significant
leftward shift of the acetylcholine-induced relaxation concentration-response curve when compared to vehicle control
(P,0.05).
Conclusion: Upregulation of caveolin-1 protein expression and reduced NO bioavailability contributes to aortic endothelial
dysfunction in AngII-infused ApoE2/2 mice.
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Introduction
Endothelial dysfunction is a common finding in patients with
atherosclerosis, abdominal aortic aneurysm (AAA) and hyperten-
sion [1,2]. Nitric oxide (NO) is a key regulator of normal
endothelial function [3]. NO is generated by endothelial nitric
oxide synthase (eNOS) by catalytic conversion of L-arginine upon
receptor activation (e.g. of the muscarinic receptor) or by
mechanical forces (e.g. by shear stress) [4,5]. eNOS is constitu-
tively expressed in endothelial cell and accumulating studies have
suggested that various cardiovascular risk factors such as diabetes
mellitus, aging and hypertension can impair endothelial function
and inhibit the NO signalling pathway [1,2,6]. In addition,
impaired acetylcholine-induced endothelium-mediated aortic va-
sodilatation and reduction of NO bioavailability have been
demonstrated during hypercholesterolemia in both animal and
human studies [7–9], suggesting an important role of NO in
dyslipidemia-induced vascular dysfunction.
Apolipoprotein E-deficient (ApoE2/2) mice are one of the most
widely used animal model of atherosclerosis and abdominal aortic
aneurysm (AAA) [10–12]. These mice develop hypercholesterol-
emia and aortic plaques when fed normal diet [13] and
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accelerated atherosclerosis when fed a high fat western-type diet
[14]. It is now widely accepted that endothelial dysfunction is one
of the early steps in atherosclerosis and AAA [1,6] and altered NO
signalling is a common feature observed in these animal models
[7,14]. Indeed, impairment of endothelium-mediated vasorelaxa-
tion in response to acetylcholine has been demonstrated in the
aorta of ApoE2/2 mice fed a western-type diet [7,14]. It is
interesting to note that when fed a normal diet [15] endothelium-
dependent relaxation remains normal up to 6 months of age in
ApoE2/2 mice. At older ages endothelial dysfunction is correlated
with the development and size of aortic plaques [13]. These
findings suggest that the endothelial dysfunction is not simply
mediated by hypercholesterolemia alone but likely involves
additional mechanisms.
Angiotensin II (AngII) infusion is commonly used to promote
atherosclerosis and AAA in ApoE2/2 mice [12]. We have recently
demonstrated that fenofibrate suppressed aortic dilatation and
atherosclerosis via increasing eNOS activity in the AngII-infused
mouse model [1], suggesting an important role of eNOS activity in
this model. Although an increase in blood pressure has been
reported in AngII-infused ApoE2/2 mice [16], impairment of
endothelium-mediated relaxation and the underlying mechanism
involved has not been fully explored in this mouse model.
eNOS activity is tightly controlled by various membrane bound
receptors and regulatory proteins under physiological conditions
[3]. Alternation of these receptors or regulatory proteins can upset
the balanced generation of NO. Caveolae are 50–100 nm cell
surface plasma membrane invaginations which are abundant in
endothelial cells [17]. It has been suggested caveolae play an
essential role in regulating NO production by interaction of eNOS
and caveolin-1 (Cav-1), a structural protein of caveolae [18].
Pharmacological disruption of caveolae has been shown to impair
NO- and endothelium-derived hyperpolarizing factor (EDHF)-
mediated acetylcholine-induced vasodilatation in isolated rat
blood vessels [18]. Cav-1 has been associated with vascular
diseases in both human and animal studies [2,19]. In Cav-12/2
ApoE2/2 mice, atherosclerotic plaque area is markedly reduced
despite the presence of hypercholesterolemia [20]. Expression of
Cav-1 mRNA and protein were reported to be significantly
upregulated in diabetic mice and endothelium-dependent re-
laxation was markedly suppressed [2]. In addition, it has been
suggested recently that amlodipine, an L-type calcium channel
blocker, can offer additional cardiovascular protective effects via
enhancement of NO production in endothelial cells by antagonis-
ing the eNOS/Cav-1 signalling complex [21]. These studies have
provided evidence that eNOS/Cav-1 interactions could be a novel
target site for therapy of cardiovascular diseases.
We hypothesized that AngII-infusion impaired vascular endo-
thelium function was associated with altered Cav-1 expression in
the aortas of ApoE2/2 mice. In this study we investigated whether
aortic vascular reactivity was altered in AngII-infused ApoE2/2
mice by measuring aortic contraction and relaxation in isolated
thoracic aortas of AngII-infused ApoE2/2 mice. We also assessed
eNOS activity and Cav-1 expression in this animal model.
Materials and Methods
Animals and Ethics Statement
This investigation conformed to the Guide for the Care and Use
of Laboratory Animals published by the US National Institute of
Health (NIH Publication No. 85-23, revised 1996). The protocol
was approved by the Animal Ethics Committee of James Cook
University (Approval Number: A1671). All surgery was performed
under intraperitoneal injection of ketamine and xylazine anesthe-
sia, topical application of local anaesthetic (Elmar) was provided as
post-operative analgesia and the animals were allowed to recover
under supplemental heat using a warming pad. Male ApoE2/2
mice (Animal Resources Centre, Western Australia) were housed
under a 12:12-h light-dark cycle (relative humidity: 55–60%;
temperature: 2261uC) and were given standard chow and water
ad libitum. At 6 months of age mice were anaesthetised by
intraperitoneal injection of ketamine (150 mg/kg) and xylazine
(10 mg/kg). Osmotic minipumps (Model 2004, ALZET, USA)
were placed into the subcutaneous space along the dorsal midline
to deliver 1 mg/kg/min of AngII (Sigma-Aldrich, Castle Hill,
Australia) dissolved in distilled water over 14 days. Age-matched
ApoE2/2 mice in which osmotic pumps delivered distilled water
served as vehicle controls. Mice were maintained on a normal
laboratory diet throughout the infusion period. After the 14 day
infusion, mice were sacrificed by CO2 asphyxiation, blood was
collected by cardiac puncture and the aortas were isolated for
further assessments.
Non-invasive Tail-cuff Blood Pressure and Heart Rate
Measurement
Blood pressure and heart rate were measured at day 0 (baseline),
day 7 and day 14 (endpoint) of the experiment using a comput-
erized, non-invasive, tail-cuff system (Kent Scintific, USA).
Animals were habituated to the device before measuring the
pressures to ensure accurate measurements. Good reproducibility
of this technique has been established previously (mean of absolute
difference for heart rate: 21.1 beats per minute, 95% confidence
interval (CI): 14.8–27.5 and mean of absolute difference for mean
blood pressure: 12.3 mmHg, 95% CI: 8.4–16.1).
Isometric Tension Measurement
Thoracic aortas (length: ,12 mm; outer diameter ,0.8 mm)
were dissected from the mice immediately after sacrifice. Fat and
connective tissues around the vessels were carefully removed under
the dissecting stereo-microscope (Leica, Germany). Myograph
studies were performed in a 5 mL small vessel wire myograph
containing physiological salt solution with the composition (mM)
of NaCl 118, CKl 4.7, MgSO4 1.2, KH2PO4 1.2, NaHCO3 25,
glucose 11 and CaCl2 1.8, as previously described [2]. Two types
of experiments were carried out: contraction of vessels and
relaxation of precontracted vessels.
In contraction studies, concentration-response curves in re-
sponse to high [K+]o (10–60 mM) and phenylephrine (0.1 nM–
3 mM) were constructed. Increasing concentrations of individual
contractile agents were administrated at half-log increments, and
the response at each concentration of drug added (expressed as the
final bath concentration) was measured using the MacLab Chart v
7.2.1 programme (AD Instruments, Australia).
In relaxation studies, to exclude the involvement of the cyclo-
oxygenase cascade and acetylcholinesterase, indomethacin (1 mM,
a selective cyclo-oxygenase inhibitor) and neostigmine (10 mM, an
acetylcholinesterase inhibitor) were included in the Krebs’ solution
in all experiments. In some preparations, the role of NOS and
caveolae were evaluated by using Nv-nitro-L-arginine methyl ester
(L-NAME) (20 mM, a NOS-inhibitor) and methyl-b-cyclodextrin
(1 mM, a cholesterol-extracting agent), respectively. All blockers
used in this study were allowed to incubate with the preparation
for 30 min before the construction of a concentration–response
curve. Increasing concentrations of individual relaxants were
administered at half-log increments at the plateau (i.e. steady-state)
of the previous response. The response at each concentration of
drug added (expressed as final bath concentration) was measured
using the MacLab Chart v 7.2.1 programme (AD Instruments,
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Australia). Relaxation in response to individual agents was
expressed as % of the phenylephrine (1 mM) contraction and
100% relaxation was considered when the active tone returned to
the baseline level.
Plasma Nitrite/nitrate and Cholesterol Measurement
Measurements of total plasma cholesterol, high density
lipoprotein (HDL) and low density/very low density lipoprotein
(LDL/VLDL) were performed in plasma in duplicate using
a commercial kit in accordance with the manufacturers’ instruc-
tions (inter-assay coefficient of variation 3.4%) (Abcam). Choles-
terol oxidase specifically recognizes free cholesterol and produces
products which react with a probe to generate fluorescence (Ex/
Em=538/587 nm) and were measured using an Omega plate
reader.
Total nitrate was measured in plasma samples by a nitrate/
nitrite colorimetric assay kit following manufacturer’s protocol
(inter-assay coefficient of variation 2.7%) (Cayman). Briefly, nitrate
was converted to nitrite using nitrate reductase. Subsequently
addition of the Griess reagents converted nitrite into a deep purple
azo compound and the absorbance was measured at 540 nm using
an Omega plate reader.
Western Blotting
Thoracic aortas were homogenized in RIPA buffer (Thermo
Scientific, USA) in the presence of protease inhibitors (Roche
Applied Science, USA) to obtain extracts of proteins. Protein
concentrations were determined using the Bradford protein assay
kit (BioRad, USA). Samples (25 mg of protein per lane) were
loaded onto a 10% SDS-polyacrylamide gel electrophoresis gel.
After electrophoresis (110 V, 90 min), the separated proteins were
transferred (15 mA, 60 min) to polyvinylidene difluoride mem-
branes (BioRad, USA). Non-specific sites were blocked with 5%
non-fat dry milk in TBSt (BioRad, USA) for 60 min, and the blots
were then incubated with anti-phospho-eNOS (Ser 1177)
antibody, 1:1000 (Cell Signalling, USA); anti-eNOS, 1:1000(Cell
Figure 1. AngII infusion increases mean blood pressure in ApoE2/2 mice. Effects of AngII infusion on (A) heart rate and (B) mean blood
pressure (MBP) in ApoE2/2 mice. Results are mean6SEM (n= 6); Statistical significance shown as ***P,0.0001.
doi:10.1371/journal.pone.0058481.g001
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Signalling, USA); or anti-Cav-1, 1:1000 (Santa Cruz, USA) in 5%
non-fat milk (BioRad, USA) overnight at 4uC. Anti-rabbit HRP
conjugated IgG, 1:1000 (DakoCytomation, Denmark) in 5% non-
fat milk (60 min, room temperature) was used to detect the
binding of its correspondent antibody. Membranes were stripped
with stripping solution (Thermo Scientific, USA) for 20 mins at
room temperature and re-blotted with anti-b actin antibody,
1:6000 (Sigma-Aldrich, USA) in 5% non-fat milk (60 min, room
temperature) to verify equal loading of protein in each lane. The
protein expression was detected with Western Lightning Chemi-
luminescence Reagent Plus (PerkinElmer Life Sciences, USA) and
quantified by Quantity One (version 4.6.7) software (BioRad,
USA).
Statistical Analysis
Data were presented as mean 6 SEM of n experiments.
Statistical comparisons were performed using t-test or two-way
analysis of variance (ANOVA), where appropriate. Differences
were considered to be statistically significant at P,0.05. All
statistical analysis was performed using GraphPad Prism 5
software (GraphPad Software, Inc., USA).
Results
Effect of AngII Infusion on Blood Pressure and Heart Rate
in ApoE2/2 Mice
AngII infusion resulted in an increase in mean blood pressure
(MBP) in ApoE2/2 mice in a time-dependent manner. MBP was
significantly higher in the AngII-infused group when compared
with the vehicle-infused group as measured at day 7 (Control vs
AngII: 88.1361.81 mmHg vs 104.9062.20 mmHg) (n = 6;
P,0.001) and day 14 (Control vs AngII: 84.3361.86 mmHg vs
119.4061.29 mmHg) (n = 6; P,0.001) (Figure 1A). Heart rate
was not altered by either AngII or vehicle infusion in ApoE2/2
mice throughout the 14-day period (Control vs AngII at day 14:
597.1069.74 bpm vs 590.10613.39 bpm) (n = 6; P.0.05)
(Figure 1B).
Effect of AngII Infusion on Vascular Relaxation of Isolated
Thoracic Aortas from ApoE2/2 Mice
Basal tone of the rings were similar in aortas from the vehicle-
and AngII-infused mice (Control: 8.8360.84 mN; AngII:
8.5260.34 mN) (P.0.05; n= 6). In aortas from vehicle-infused
ApoE2/2 mice acetylcholine (0.1 nM –3 mM) caused a concen-
tration-dependent relaxation of the isolated thoracic aorta with
100% relaxation at ,1 mM (Figure 2A). The acetylcholine-
induced relaxation of aortas from AngII -infused mice was
significantly smaller than that observed in aortas from control
mice. There was a marked rightward shift of the concentration-
response curve to acetylcholine (EC50: Control: 26.362.09 nM;
AngII: 798.761.40 nM) and a reduced maximum relaxation
response at 3 mM (Control: 114.668.93; AngII: 65.98613.33)
(n = 5–6; P,0.05) (Figure 2A). In addition, the acetylcholine-
induced relaxation was greatly suppressed by L-NAME (20 mM) in
aortas from both vehicle- and AngII -infused mice (Figure 2A).
Cumulative administration of sodium nitroprusside (SNP)
(0.1 nM–3 mM) caused a concentration-dependent relaxation of
isolated thoracic aortas from both vehicle- and AngII -infused
mice. No significant difference was observed in the SNP-induced
relaxation of aortas from the two groups (Figure 2B).
Effect of AngII Infusion on Vascular Contraction of
Isolated Thoracic Aortas from ApoE2/2 Mice
Cumulative administration of phenylephrine (0.1 nM- 3 mM)
caused a concentration-dependent contraction of isolated thoracic
aortas from vehicle-infused ApoE2/2 mice. A significant leftward
shift of the concentration-response curve to phenylephrine was
observed in the isolated aortas from the AngII-infused mice (EC50:
Control: 294.865.18 nM; AngII: 83.964.15 nM) (P,0.01; n = 5–
6) (Figure 2C). Similarly, potassium chloride (10–60 mM), caused
a concentration dependent contraction of the isolated aortas of
ApoE2/2 mice with a significant leftward shift of the concentra-
tion-response curve observed in AngII-infused mice when
compare with the vehicle-infused animals (EC50: Control:
26.6762.90 mM; AngII: 15.2764.89 mM) (P,0.0001; n = 5–6)
(Figure 2D).
Effect of AngII Infusion on Cav-1, p-eNOS(Ser1177) and
Total eNOS Protein Expression in the Thoracic Aortas of
ApoE2/2 Mice
Protein expression of Cav-1, p-eNOS and total eNOS in the
isolated thoracic aortas were evaluated and compared between the
vehicle-infused and AngII-infused ApoE2/2 mice. Our results
revealed that there was significant upregulation of Cav-1 protein
expression in aortic sample from AngII-infused mice (n = 6;
P,0.05) (Figure 3A). Expression of p-eNOS (Ser1177) and total
eNOS protein in the isolated aortas from the two groups of mice
were compared. Expression of total eNOS was similar in the
aortas of saline- and AngII mice. A marked reduction of p-
eNOS(Ser1177) expression was observed in aortas from the AngII-
infused mice when compared to the vehicle-infused mice (n = 6;
P,0.05) (Figure 3B).
Effect of AngII Infusion on Plasma Nitrite/nitrate, Total
Cholesterol, High Density Lipoprotein (HDL) and Very
Low Density Lipoprotein (VLDL) in ApoE2/2 Mice
Plasma total cholesterol, HDL and VLDL were not significantly
different between vehicle- and AngII-infused mice (Figure 4A, B
and C). Total plasma nitric oxide metabolite (nitrite/nitrate) level
was significantly lower (,2 fold) in AngII-infused mice (n = 5;
P,0.05) (Figure 4D).
Effect of Methyl-b-cyclodextrin on Acetylcholine-induced
Relaxation in Isolated Aortas from Vehicle- and AngII-
infused ApoE2/2 Mice
The effect of chemical disruption of caveolae on acetylcholine-
induced relaxation was studied in isolated aortas of vehicle- and
AngII-infused mice. The isolated aortas were preincubated either
with methyl-b-cyclodextrin (MbCD) or without (non-MbCD) for
60 minutes prior to construction of concentration-response curves.
Neither MbCD or non- MbCD pre-incubation influenced baseline
tone at any time. In the presence of MbCD, the acetylcholine-
induced relaxation in isolated aortas from AngII-infused mice was
Figure 2. AngII infusion alters aortic relaxations and contractions in ApoE2/2 mice. (A) Concentration-response curve of endothelium-
dependent relaxation to acetylcholine, with or without the present of L-NAME (20 mM) and (B) endothelium-independent relaxation to SNP in aortas
of saline-infused (Veh) and AngII-infused (AngII) ApoE2/2 mice. (C) Concentration-response curve to phenylephrine- and (D) KCl-induced contraction
in aortas of saline-infused (Veh) and AngII -infused (AngII) ApoE2/2 mice. Results are mean6SEM; (n = 5–6); Statistical significance shown as *P,0.05;
**P,0.01 and ***P,0.0001.
doi:10.1371/journal.pone.0058481.g002
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significantly greater at 3 mM (Control: 44.72611.62; MbCD:
75.0764.07) (P,0.05; n= 5) with a leftward shift of the
concentration-response curve when compare with the non-MbCD
treated aortas. However, MbCD did not alter acetylcholine-
Figure 3. AngII infusion alters aortic Cav-1 and phospho-eNOS expressions. (A) Representative Western blot analysis of caveolin-1 protein
expression in aortas of saline-infused (Veh) and AngII-infused (AngII) ApoE2/2 mice. Bar chart indicates results of relative densitometry analysis of
caveolin-1 protein relative to b-actin. (B) Representative Western blot analysis of phospho-eNOS (Ser1177) and total eNOS protein expression in
aortas of saline-infused (Veh) and AngII -infused (AngII) ApoE2/2 mice. Bar chart indicates results of relative densitometry analysis of p-eNOS protein
relative to total eNOS. Results are mean6SEM; n= 6; Statistical significance shown as *P,0.05.
doi:10.1371/journal.pone.0058481.g003
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induced relaxation in isolated aortas from the vehicle-infused mice
(P.0.05; n= 5) (Figure 5).
Discussion
This study demonstrates for the first time that an increase in
caveolin-1 protein expression is associated with the impairment of
acetylcholine-induced endothelium-dependent aortic relaxation
found in AngII-infused ApoE2/2 mice. It is well known that
malfunction of the endothelium is a hallmark of vascular diseases
seen in patients with hypertension and atherosclerosis. Our results
suggest that upregulation of caveolin-1 protein expression and
reduced NO bioavailability contributes to aortic endothelial
dysfunction in AngII-infused ApoE2/2 mice.
Classically, relaxation of blood vessels by acetylcholine is
mediated by NO generated from eNOS and activation of soluble
guanylyl cyclase [2]. Previous studies have demonstrated that
acetylcholine, but not DEA-NONOate (a NO-donor), induced
vascular relaxation was reduced in hypercholesterolemic ApoE2/
2 mice [22,23]. Similarly, in this study, we observed a marked
decrease in acetylcholine-induced aortic relaxation in AngII-
infused ApoE2/2 mice suggesting reduction of eNOS activity. It is
important to note that the acetylcholine-induced relaxation was
substantially inhibited by L-NAME, an eNOS inhibitor, confirm-
ing that the relaxation was mediated by eNOS-derived NO.
Although altered responsiveness to NO in vascular smooth muscle
cells (VSMCs) has been observed in ApoE2/2 mice [7], the
preserved SNP-induced endothelium-independent relaxation ob-
served in our current study suggests the impaired relaxation was
not a consequence of changes in soluble guanylyl cyclase activity
and/or subsequent cGMP formation in VSMCs. An enhanced
vasoconstriction response to a-adrenoceptor agonist without
alteration in endothelium function was previously reported in
ApoE2/2 mice [24]. We observed that the increased vasocon-
striction response was not limited to an a-adrenoceptor agonist (ie.
receptor-mediated response), but was also demonstrated in
response to KCl (i.e. non-receptor-mediated response) in AngII-
infused mice. The possible explanation for this alteration in both
receptor-mediated and non-receptor-mediated vasoconstriction is
that endothelial NO is basally released as a buffering mechanism
limiting the magnitude of vascular contraction response under
normal physiological conditions [23,25]. In the case of endothelial
dysfunction, this balance could be upset resulting in an enhanced
contraction response. In agreement with this hypothesis, we
noticed a significant reduction in plasma nitrite and nitrate levels
in AngII-infused mice. A reduced phenylephrine-induced aortic
contraction was reported in hypercholesteremic rabbits in
association with an alteration of the cyclooxygenase (COX)
signalling pathway [26]. In this study, plasma cholesterol level
was not different between the AngII- and vehicle- infused mice,
minimizing the possibility that the observed responses were
mediated by hypercholesteremia-altered COX signalling. Collec-
tively, these data support the idea that altered vascular reactivity in
AngII infused ApoE2/2 mice is mediated by impaired endothelial
function.
Phosphorylayion of eNOS at the Ser1177 residue is one of the
major steps in eNOS activation [3]. The decreased ratio of p-
eNOS to eNOS in the thoracic aortas of AngII-infused mice
observed in our study suggests a decreased efficiency of eNOS
activation by a mechanism which limits the phosphorylation of this
enzyme at the Ser1177 site. Numerous studies have suggested that
eNOS can directly interact with the scaffolding domain of Cav-1,
a major structural protein of caveolae [17,27]. Increased NO
production and reduced arterial myogenic tone have been
Figure 4. Effects of AngII infusion on plasma nitrite/nitrate,
total cholesterol, high density lipoprotein (HDL) and very low
density lipoprotein (VLDL). Box plots showing plasma (A) total
cholesterol; (B) HDL, (C) VLDL and (D) total NO metabolites in saline-
infused (Veh) and AngII -infused (AngII) ApoE2/2 mice. Results are
mean6SEM; n = 5; Statistical significance shown as *P,0.05.
doi:10.1371/journal.pone.0058481.g004
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observed in Cav-1 knockout mice. These studies clearly indicate
an essential role of Cav-1 in the negative regulation of eNOS
activity [17,28]. Furthermore, increased Cav-1 mRNA and
protein expression have been observed in the cardiovascular
preparations of diabetic obese mice [2] and in rats received high
salt intake [29], in association with impaired eNOS activity. These
reports further support the idea that altered expression of Cav-1
could be associated with endothelial dysfunction in vascular
diseases. Our results demonstrate for the first time that aortic Cav-
1 protein expression was markedly upregulated in ApoE2/2 mice
receiving AngII infusion. Bodor et al have recently shown that
AngII infusion increases permeability of human cultured umbilical
vein endothelial cells (HUVECs) by upregulation of PV-1 protein
expression and increased caveolae accumulation at cell mem-
branes and within the cytoplasm [30]. These results further
strengthen the idea that AngII could contribute to the regulation
of Cav-1 expression and/or caveolae formation. Finally, we
provided additional evidence for the role of Cav-1/caveloae in the
reduced endothelium-dependent acetylcholine-induce aortic re-
laxation in AngII-infused ApoE2/2 mice by disrupting caveolae
and membrane fluidity pharmacologically [31]. Methyl-b-cyclo-
dextrin (MbCD), a cholesterol-binding agent, partially restored the
acetylcholine-induced aortic relaxation in the AngII-infused mice,
indicating the importance of caveolae and functional properties of
membranes in acetylcholine-mediated eNOS signalling trans-
duction. Although, most previous reports demonstrated a reduced
relaxant response to acetylcholine after MbCD treatment, it is
important to point out that, responses observed from those studies
were conducted on vascular preparations from animals which
were free from AngII treatment and/or diseases [18,31]. In-
terestingly, a recent study by Burger et al demonstrated that AngII
induced hypertension in ApoE2/2 mice involves microparticle
formation and increased endothelial superoxide generation where
release of the microparticles were blocked by membrane/caveloae
disruption using MbCD [32]. Hence, it is possibly that the
enhanced endothelium-dependent response in our study was
mediated by both Cav-1/eNOS interaction and inhibition of
endothelial-derived microparticle generation.
The AngII-infused ApoE2/2 mouse model used in this study is
a widely used animal model in atherosclerosis and aneurysm
research [12]. Consistent with previous reports [16], the present
study demonstrated that blood pressure was elevated in a time-
dependent manner in ApoE2/2 mice infused with AngII. The
magnitude of the blood pressure elevation (,35 mmHg) in our
study was ,10 mmHg higher when compared to that previously
shown [16]. The use of ApoE2/2 mouse of older age (6 months vs
2 months) in this study could have contributed to this discrepancy,
since enhanced blood pressure and sensitivity to AngII in aged
ApoE2/2 mice have been previously reported [33]. Previous
studies have suggested that the elevation of blood pressure by
AngII infusion is simply due to the vasoconstriction property of
AngII and independent from AAA and atherosclerosis [16]. It is
interesting to point out that, our current results clearly demon-
strated a reduced endothelium-dependent aortic relaxation in the
AngII-infused mice indicating AngII infusion could alter vascular
reactivity beyond its vasoconstriction property. Moreover, recent
studies from our group and others have demonstrated the
important role of eNOS activity in AAA and atherosclerosis in
the AngII-infused mouse model [1,6], suggesting a possible link
between AngII and the pathogenesis of diseases involving
endothelium dysfunction. A recent clinical report has suggested
that arterial diseases are associated with disturbed interaction
between Cav-1 and eNOS [19]. Finally, previous studies have
suggested that upregulation of cell adhesion molecules expression,
such as ICAM -1 and VCAM-1, play an important role in
atherosclerosis development [34,35]. Endothelium dysfunction,
including reduced eNOS activity, is closely associated with the
enhanced endothelial ICAM-1 expression in ApoE2/2 mice [36].
Although this is not explored in the current study, it is logical to
hypothesize that AngII-induced atherosclerosis in ApoE2/2
mouse is, at least, partly mediated by the increased Cav-1-
mediated suppression of eNOS activity. Putting all these together,
our results highlight the possible important role of Cav-1 in
endothelium function in AngII-infused ApoE2/2 mice. This
finding may allow for the development and investigation of new
drugs for cardiovascular conditions by targeting Cav-1.
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Figure 5. Effects of chemical disruption of caveolae on acetylcholine-induced aortic relaxation. Concentration-response curve of
endothelium-dependent relaxation to acetylcholine in aortas of vehicle- and AngII -infused ApoE2/2 mice with or without the presence of methyl-b-
cyclodextrin (MbCD) (1 mM). Results are mean6SEM and expressed as percentage of relaxation of the submaximal contraction of phenylephrine
(1 mM) (n = 5); Statistical significance shown as *P,0.05 and **P,0.01.
doi:10.1371/journal.pone.0058481.g005
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